Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  PDF of this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box Social Bookmarking
 Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter
What's this?
box PubMed
Articles in PubMed by Author:
 arrow  Carrascosa, M.
space
 arrow  Perez-Castrillon, J. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Hemorrhagic Proctosigmoiditis and Blastocystis hominis Infection

right arrow Miguel Carrascosa, MD; Josefina Martinez, MD; and Jose L. Perez-Castrillon, MD

15 January 1996 | Volume 124 Issue 2 | Pages 278-279


TO THE EDITOR:

Blastocystis hominis is a protozoan organism frequently found in the human intestinal tract. Controversy surrounds the clinical consequences of infection with this organism: Some researchers strongly believe B. hominis is pathogenic, others believe it is not responsible for clinical symptoms when detected, and still others believe the question of pathogenicity is unsettled [1-5]. We report a case of hemorrhagic proctosigmoiditis believed to be caused by B. hominis infection.

A 76-year-old man presented with generalized abdominal cramps, grossly bloody diarrhea, tenesmus, and fecal urgency that had lasted 24 hours. The patient did not have a fever. He had not drunk water from any source other than the public utility, eaten processed meat, or travelled to foreign countries. No other family members had similar symptoms. A stool specimen was positive for fecal leukocytes and contained numerous B. hominis organisms (30 organisms per 40 times-magnified field); no other ova or parasites were seen. Stool cultures were negative for Clostridium difficile, Salmonella, Shigella, Yersinia, Campylobacter, and Vibrio organisms; Clostridium difficile toxin was not detected. The stool was not examined for viruses or Shiga-like toxins. Results of a serologic test for human immunodeficiency virus was negative. Sigmoidoscopy showed marked diffuse erythema, and examination of multiple rectal and sigmoid biopsy specimens showed moderate acute inflammation not consistent with idiopathic inflammatory bowel disease. Results of mesenteric and celiac arteriography, barium enema, and abdominal ultrasonography were normal.

After treatment with metronidazole, 750 mg three times a day for 7 days, the symptoms resolved. Stool examinations done 2 and 7 weeks after treatment showed no evidence of B. hominis or other enteric pathogens. The patient remained well 2 months after therapy, and findings of a second sigmoidoscopy with biopsy were normal.

We believe this case provides further evidence to support the pathogenicity of B. hominis and that this organism should be considered a possible additional cause of hemorrhagic colitis in both immunocompetent and immunocompromised persons.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Hospital of Laredo Cantabria, Spain


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1.  Vannatta JB, Adamson D, Mullican K.Blastocystis hominis infection presenting as recurrent diarrhea. Ann Intern Med. 1985; 102:495-6.

2.  Miller RA, Minshew BH.Blastocystis hominis: an organism in search of a disease. Rev Infect Dis. 1988; 10:930-8.

3.  Zierdt CH.Blastocystis hominis. Past and future. Clin Microbiol Rev. 1991; 4:61-79.

4.  "Blastocystis hominis: commensal or pathogen? [Editorial]. Lancet. 1991; 337:521-2.".

5.  Al-Tawil YS, Gilger MA, Gopalakrishna GS, Langston C, Bommer KE. Invasive Blastocystis hominis infection in a child. Arch Pediatr Adolesc Med. 1994; 148:88.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?





 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1996 by the American College of Physicians.